We are committed to finding a cure for WM.

Latest WM Publications

The following six publications posted here are given out by the Bing Center. They can be beneficial to patient and caregivers. Topics include genomics, treatment options, latest information on ibrutinib, Bing Neel Syndrome, National Comprehensive Cancer Network guidelines for WM booklet and two articles from the 8th International Workshop on WM.

 

  1. Ibrutinib in Previously Treated Waldenstrom’s Macroglobulinemia
  2. Doctors and Patient Advocates are Working Tirelessly for Waldesntrom Macroglobulinemia
  3. Future therapeutic options for patients with Waldenstrom Macroglobulinemia
  4. Investigation and management of IgM and Waldenstrom aassociated peripheral neuropathies: recommendations from the IWWM-8 consensus panel
  5. How I treat Waldenstrom macroglobulinemia – Steven Treon
  6. Ibrutinib in Previously Treated Waldenstroms macroglobulinemia
  7. CXCL 13 Levels are elevated in patients with Waldenstroms Macroglobulinemia and are predictive of major response to ibrutinib
  8. Idelalsib in Waldenstrom Macroglobulinemia: High incidence of hepatoxicity
  9. Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenstroms macroglobulinemia
  10. Comparative outcomes in immunochemotherapy regimens in Waldenstroms macroglobulinemia
  11. The importance of the genomic landscape in Waldenstroms Macroglobulinemia for targeted therapeutical interventions

 

12. Genomics, Signaling and Treatment of Waldenstrom Macroglobulinemia

13. Ibrutinib for patients with rituximab-refractory
Waldenström’s macro globulinaemia (iNNOVATE):
an open-label substudy of an international, multicentre,
phase 3 trial

14. Guideline for the diagnosis, treatment and response criteria for Bing Neel syndrome

 15. NCCN Guidelines for Patients – Waldenstrom’s Macroglobulinemia Lymphoplasmacytic Lymphoma

16. Recommendations for the diagnosis and initial evaluation of patients with Waldenstrom Macroglobulinaemia: A Task Force from the 9th International Workshop on Waldenstrom Macroglobulinaemia

17. Treatment recommendations from the Eighth International Workshop on Waldenstrom Macroglobulinemia